Jiangsu Hengrui Medicine Co., Ltd. 600276.SS Stock
Jiangsu Hengrui Medicine Co., Ltd. Price Chart
Jiangsu Hengrui Medicine Co., Ltd. 600276.SS Financial and Trading Overview
| Jiangsu Hengrui Medicine Co., Ltd. stock price | 44.56 CNY |
| Previous Close | 46.93 CNY |
| Open | 46.8 CNY |
| Bid | 47.49 CNY x 0 |
| Ask | 47.5 CNY x 0 |
| Day's Range | 46.7 - 48.48 CNY |
| 52 Week Range | 31.88 - 50.3 CNY |
| Volume | 38.03M CNY |
| Avg. Volume | 36.35M CNY |
| Market Cap | 303B CNY |
| Beta (5Y Monthly) | 0.289041 |
| PE Ratio (TTM) | 77.86885 |
| EPS (TTM) | 0.66 CNY |
| Forward Dividend & Yield | 0.16 (0.36%) |
| Ex-Dividend Date | June 8, 2023 |
| 1y Target Est | 55.99 CNY |
600276.SS Valuation Measures
| Enterprise Value | 290.76B CNY |
| Trailing P/E | 77.86885 |
| Forward P/E | 52.77778 |
| PEG Ratio (5 yr expected) | 4.17 |
| Price/Sales (ttm) | 14.232784 |
| Price/Book (mrq) | 7.964453 |
| Enterprise Value/Revenue | 13.658 |
| Enterprise Value/EBITDA | 82.436 |
Trading Information
Jiangsu Hengrui Medicine Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.289041 |
| 52-Week Change | 40.63% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 50.3 CNY |
| 52 Week Low | 31.88 CNY |
| 50-Day Moving Average | 46.97 CNY |
| 200-Day Moving Average | 41.47 CNY |
600276.SS Share Statistics
| Avg. Volume (3 month) | 36.35M CNY |
| Avg. Daily Volume (10-Days) | 30.37M CNY |
| Shares Outstanding | 6.38B |
| Float | 3.49B |
| Short Ratio | N/A |
| % Held by Insiders | 51.36% |
| % Held by Institutions | 11.36% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.16 |
| Trailing Annual Dividend Yield | 0.34% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.26229998 |
| Last Split Factor | 1.2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 18.35% |
| Operating Margin (ttm) | 14.03% |
| Gross Margin | 83.52% |
| EBITDA Margin | 16.56% |
Management Effectiveness
| Return on Assets (ttm) | 4.54% |
| Return on Equity (ttm) | 10.07% |
Income Statement
| Revenue (ttm) | 21.29B CNY |
| Revenue Per Share (ttm) | 3.32 CNY |
| Quarterly Revenue Growth (yoy) | 0.29% |
| Gross Profit (ttm) | N/A |
| EBITDA | 3.53B CNY |
| Net Income Avi to Common (ttm) | 3.91B CNY |
| Diluted EPS (ttm) | 0.61 |
| Quarterly Earnings Growth (yoy) | 0.20% |
Balance Sheet
| Total Cash (mrq) | 15.98B CNY |
| Total Cash Per Share (mrq) | 2.45 CNY |
| Total Debt (mrq) | 93.91M CNY |
| Total Debt/Equity (mrq) | 0.24 CNY |
| Current Ratio (mrq) | 12.083 |
| Book Value Per Share (mrq) | 5.964 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.33B CNY |
| Levered Free Cash Flow (ttm) | -1551977472 CNY |
Profile of Jiangsu Hengrui Medicine Co., Ltd.
| Country | China |
| State | N/A |
| City | Lianyungang |
| Address | No. 38, Huanghe Road |
| ZIP | 222000 |
| Phone | N/A |
| Website | https://www.hrs.com.cn |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 20636 |
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, develops, manufactures, and commercializes drugs worldwide. The company is developing Camrelizumab, Pyrotinib, Fuzuloparib, Adebrelimab, Rezvilutamide, Famitinib, Dalpiciclib, SHR-1701, SHR-1501, SHR-A1811, SHR1459, Mecapegfilgrastim, Apatinib, Linperlisib, and SHR2554 for oncology indications; SHR4640, Retagliptin, SHR20004, SHR-1209, SHR3824, INS068, SHR7280, and SHR2285 for cardiovascular and metabolism indications. It is also developing SHR0302, Hetrombopag, Vunakizumab, and SHR-1703 for autoimmune indications; SHR0410, Imrecoxib, Remimazolam, and SHR8554 for pain; Oteseconazole and HRS9950 for anti-infection; and SHR8028, SHR8058, SHR-1707, and SHR-1222 for other indications. The company was founded in 1970 and is based in Lianyungang, China.
Q&A For Jiangsu Hengrui Medicine Co., Ltd. Stock
What is a current 600276.SS stock price?
Jiangsu Hengrui Medicine Co., Ltd. 600276.SS stock price today per share is 44.56 CNY.
How to purchase Jiangsu Hengrui Medicine Co., Ltd. stock?
You can buy 600276.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jiangsu Hengrui Medicine Co., Ltd.?
The stock symbol or ticker of Jiangsu Hengrui Medicine Co., Ltd. is 600276.SS.
Which industry does the Jiangsu Hengrui Medicine Co., Ltd. company belong to?
The Jiangsu Hengrui Medicine Co., Ltd. industry is Drug Manufacturers-General.
How many shares does Jiangsu Hengrui Medicine Co., Ltd. have in circulation?
The max supply of Jiangsu Hengrui Medicine Co., Ltd. shares is 6.42B.
What is Jiangsu Hengrui Medicine Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Jiangsu Hengrui Medicine Co., Ltd. PE Ratio is 67.92424000 now.
What was Jiangsu Hengrui Medicine Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Jiangsu Hengrui Medicine Co., Ltd. EPS is 0.66 CNY over the trailing 12 months.
Which sector does the Jiangsu Hengrui Medicine Co., Ltd. company belong to?
The Jiangsu Hengrui Medicine Co., Ltd. sector is Healthcare.